REKENCT
Live / Applied — First extension granted (statement of use) (as of 01 Apr 2026)
What this means for you
Not registered yet, but its 24 Apr 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99154221
- Mark type
- Stylized text
- Filed
- 24 Apr 2025
- Published for opposition
- 04 Nov 2025
- Attorney of record
- April Wurster
Goods and services
- Class 005 — Pharmaceuticals: Therapeutic pharmaceutical preparations for the treatment of neurodegenerative diseases
Owner
- Kenai Therapeutics, Inc., Cambridge, MA, US
- Kenai Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 02 Apr 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Apr 2026 — SOU EXTENSION 1 GRANTED
- 01 Apr 2026 — SOU EXTENSION 1 FILED
- 01 Apr 2026 — SOU TEAS EXTENSION RECEIVED
- 30 Dec 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 04 Nov 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 04 Nov 2025 — PUBLISHED FOR OPPOSITION
- 29 Oct 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Oct 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 Sept 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 22 Sept 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 22 Sept 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 17 Sept 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 17 Sept 2025 — NON-FINAL ACTION E-MAILED
- 17 Sept 2025 — NON-FINAL ACTION WRITTEN